These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19913862)

  • 21. A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus.
    Maier CC; Delagrave S; Zhang ZX; Brown N; Monath TP; Pugachev KV; Guirakhoo F
    Virology; 2007 Jun; 362(2):468-74. PubMed ID: 17303204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locus of a virus neutralization epitope on the Japanese encephalitis virus envelope protein determined by use of long PCR-based region-specific random mutagenesis.
    Morita K; Tadano M; Nakaji S; Kosai K; Mathenge EG; Pandey BD; Hasebe F; Inoue S; Igarashi A
    Virology; 2001 Sep; 287(2):417-26. PubMed ID: 11531418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Jan; 11(1):57-65. PubMed ID: 19006097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability.
    Liang JJ; Liao CL; Liao JT; Lee YL; Lin YL
    Vaccine; 2009 May; 27(21):2746-54. PubMed ID: 19366580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants.
    Ni H; Barrett AD
    Virology; 1998 Feb; 241(1):30-6. PubMed ID: 9454714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Japanese encephalitis virus by reverse transcription/polymerase chain reaction.
    Paranjpe S; Banerjee K
    Acta Virol; 1998 Feb; 42(1):5-11. PubMed ID: 9645237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation and identification of Japanese encephalitis virus in Liaoning Province].
    Wang JW; Fu SH; Wang HY; Mao XY; Liu WB; He Y; Sun XH; Cai ZL; Wu LP; Zhao XF; Han RH; Jing Y; Liang GD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):61-5. PubMed ID: 16642222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reverted virulence of attenuated tick-borne encephalitis virus mutant is not accompanied with the changes in deduced viral envelope protein amino acid sequence.
    Kaluzová M; Elecková E; Zuffová E; Pastorek J; Kaluz S; Kozuch O; Labuda M
    Acta Virol; 1994 Jun; 38(3):133-40. PubMed ID: 7817894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of the short variable region of the Japanese encephalitis virus 3' NTR.
    Kato F; Kotaki A; Yamaguchi Y; Shiba H; Hosono K; Harada S; Saijo M; Kurane I; Takasaki T; Tajima S
    Virus Genes; 2012 Apr; 44(2):191-7. PubMed ID: 22057659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of JEV E-HSP70 (Mycobacterium tuberculosis) fusion protein on immune response in BALB/c mice].
    Ge FF; Qiu YF; Yang YW; Chen PY
    Wei Sheng Wu Xue Bao; 2005 Jun; 45(3):441-5. PubMed ID: 15989243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and E protein expression of mutant strains during persistent infection of KN73 cells with Japanese encephalitis virus.
    Feng G; Takegami T; Zhao G
    Chin Med J (Engl); 2002 Sep; 115(9):1324-7. PubMed ID: 12411104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of full-length genome of Japanese encephalitis virus (KV1899) isolated from pigs in Korea.
    Yang DK; Kim BH; Kweon CH; Kwon JH; Lim SI; Han HR
    J Vet Sci; 2004 Sep; 5(3):197-205. PubMed ID: 15365233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.
    Lin CW; Liu KT; Huang HD; Chen WJ
    Biotechnol Lett; 2008 Feb; 30(2):205-14. PubMed ID: 17876533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: generation of attenuated strains of the virus.
    Chiou SS; Chen WJ
    Vaccine; 2007 Dec; 26(1):15-23. PubMed ID: 18045754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine.
    Risatti GR; Holinka LG; Fernandez Sainz I; Carrillo C; Kutish GF; Lu Z; Zhu J; Rock DL; Borca MV
    Virology; 2007 Aug; 364(2):371-82. PubMed ID: 17418362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An amino acid substitution (V3I) in the Japanese encephalitis virus NS4A protein increases its virulence in mice, but not its growth rate in vitro.
    Yamaguchi Y; Nukui Y; Tajima S; Nerome R; Kato F; Watanabe H; Takasaki T; Kurane I
    J Gen Virol; 2011 Jul; 92(Pt 7):1601-1606. PubMed ID: 21411676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice.
    Tajima S; Shibasaki KI; Taniguchi S; Nakayama E; Maeki T; Lim CK; Saijo M
    Heliyon; 2019 Nov; 5(11):e02882. PubMed ID: 31799464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E sequence analysis of persistently infected mutant Japanese encephalitis virus strains.
    Li Q; Xu K; Wang H; Zhou X
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):408-10. PubMed ID: 17120734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of large and small-plaque variants in the Zika virus clinical isolate ZIKV/Hu/S36/Chiba/2016.
    Kato F; Tajima S; Nakayama E; Kawai Y; Taniguchi S; Shibasaki K; Taira M; Maeki T; Lim CK; Takasaki T; Saijo M
    Sci Rep; 2017 Nov; 7(1):16160. PubMed ID: 29170504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.